Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.880
-0.210 (-6.80%)
At close: Oct 2, 2026, 4:00 PM EDT
2.867
-0.013 (-0.47%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Lexaria Bioscience Market Cap
Lexaria Bioscience has a market cap or net worth of $4.76 million as of October 2, 2026. Its market cap has decreased by -75.08% in one year.
Market Cap
4.76M
Enterprise Value
1.23M
1-Year Change
-75.08%
Ranking
Category
Stock Price
$2.88
ChartMarket Cap Chart
Since January 12, 2021, Lexaria Bioscience's market cap has decreased from $18.20M to $4.76M, a decrease of -73.85%. That is a compound annual growth rate of -20.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 4.80M | -64.96% |
| Dec 31, 2025 | 13.70M | -62.67% |
| Dec 31, 2024 | 36.70M | 186.72% |
| Dec 29, 2023 | 12.80M | -12.33% |
| Dec 30, 2022 | 14.60M | -36.80% |
| Dec 31, 2021 | 23.10M | 26.92% |
| Jan 12, 2021 | 18.20M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM ImmunoTech | 5.48M |
| Processa Pharmaceuticals | 5.40M |
| Kairos Pharma | 5.28M |
| Xenetic Biosciences | 5.25M |
| Liminatus Pharma | 5.24M |
| 60 Degrees Pharmaceuticals | 4.89M |
| Ernexa Therapeutics | 4.83M |
| NuCana | 4.70M |